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Background/aim: Blood transfusion is associated with immunosuppression, referred to as transfusion-related immunomodulation
(TRIM). In this study, for the first time, changes in the concentration of TGF-β and TNF-α were measured postoperatively in orthopedic
patients with intraoperational allogeneic red blood cell transfusion. Considering the use of packed cell units with different ages, it is
possible to suggest the more appropriate product for clinical applications.
Materials and methods: Two groups of 35 orthopedic surgery patients (with or without transfusion as case and control groups,
respectively) were involved. Serum levels of TNF-α and TGF-β were measured by ELISA.
Results: The data suggested significant differences in age (P = 0.0001), lowered hemoglobin (P = 0.003), and hematocrit (P = 0.003)
between the control and case groups. Pre- and postoperation levels of TNF-α and TGF- βwere not significantly different, but the results
showed significant increases in levels of both cytokines after the operation (P = 0.0001) in both groups.
Conclusion: Increased levels of TNF-α and TGF-β are probably related to surgery and packed cell transfusion, respectively. Further
studies using more packed cell units or other blood products and assessment of more cytokines are needed to have better understanding
about this issue.
Key words: Blood transfusion, orthopedic surgery, TNF-α, TGF- β

1. Introduction
Healthy blood is a lifesaver. Many people require blood and
its products globally in everyday life. One of every 3 people
requires transfusion of blood and its related products in
his/her life. Currently, despite the salient developments
in medical sciences an alternative for blood has not been
yet invented and only donated blood can save people from
dying. The absence of an appropriate alternative for blood,
limitations in storage time of blood and its products, and
continual need for transfusion have made blood donation
a special event (1).
Blood transfusion is defined as transient transplantation
of cells and a vast amount of antigens, which obeys organ
transplantation rules, via vascular injection. Similar to
every other treatment, this event can cause beneficial or
harmful outcomes in patients. There is no doubt about
the effectiveness of blood transfusion and similar to every
* Correspondence: noroozi_1895@yahoo.com

other treatment its advantages and disadvantages have
been determined (2). The major obstacles and side effects
of allogeneic transfusion are of immunologic nature. One
type of the delayed transfusion reactions is transfusionrelated immunomodulation (TRIM). Some of the possible
clinical outcomes of TRIM are postoperative infection and
recurrence of cancer and, on the other hand, lower graft
rejection in kidney transplant recipients (3,4).
TRIM has an important effect on the world’s public
health (5). Therefore, studies with efficient and clear
results in the field of blood transfusion in various patients
who experience difficult operations are required.
There is a lack of literature data about the impact of blood
transfusion on the serum levels of immunosuppressive
TGF-β and proinflammatory TNF-α cytokines, although
these cytokines are important mediators in the immune
system. In this study, for the first time, changes in the
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concentration of cytokines TGF-β and TNF-α were
directly measured postoperatively in orthopedic patients
with intraoperational allogeneic red blood cell transfusion.
Here we aim to investigate new TRIM-related strategies
and take a step towards clarifying the mechanisms
underlying transfusion-related immunosuppression.
In the present study, considering the use of packed
cell units with different ages, it is possible to suggest a
more appropriate product for clinical applications, for
instance, in order to reduce the risk of kidney rejection,
postoperational infections, or cancer relapse (6–8). These
items will result in providence in health and care costs via
shortening the hospitalization time and aiding the better
outcomes of patients.
2. Materials and methods
2.1. Subjects
Seventy orthopedic operation patients were involved in
this study. The study was approved by the local research
ethics committee and informed consent was obtained from
all patients. Patients’ specifications and possible involved
factors were recorded. The inclusion and exclusion criteria
are summarized in Table 1.
The median age of patients was 51 years (range 20–
65). Among them, 34 (51.4%) patients were men and 36
(48.6%) were women. All patients were divided into two
groups: the control group consisted of 35 patients who did
not receive any blood product during the operation and
the case group comprised 35 patients who received blood
in the form of packed cells in an amount relative to their
blood loss during the operation.
Peripheral venous blood was obtained from each
patient 15 min before surgery and serum was separated.
The same procedure was carried out immediately after the
operation. The samples were frozen and stored at –70 °C
until assayed.
2.2. ELISA
Levels of cytokines were determined by a sandwich
enzyme-linked
immunosorbent
assay
(ELISA)
method. A commercially available ELISA kit (Boster
biological technology- China) was used according to the
manufacturer’s instructions to quantify the concentrations
of tumor necrosis factor-alpha (TNF-α) and transforming

growth factor-β1 (TGF-β). Brieﬂy, standards and samples
were added to a microplate precoated with an antibody
against each cytokine. After incubation and removal of the
unbound substances, an enzyme-conjugated secondary
antibody speciﬁc for each cytokine was added. After a
second wash, a substrate solution was added and a yellow
color developed in proportion to the amount of the bound
cytokine in the ﬁrst step. The color development was stopped
by adding the stop solution, and optical density at 450 nm
was measured using the microplate reader (HumaReader
HS, Germany). All measurements were performed in
triplicate.
2.3. Statistical analysis.
Statistical comparisons were made using ANOVA and P <
0.05 was considered signiﬁcant. The results are expressed as
mean ± SD.
3. Results
The case group had significantly older age and longer
duration of operation (P = 0.0001) as well as lower
hemoglobin and hematocrit (P = 0.003) when compared to
the control group (as shown in Table 2).
However, there was no significant difference between
the two groups in terms of the basal and postoperation state
of TGF-β and TNF-α (P > 0.05) (as shown in Tables 3 and
4 and Figure 1).
Furthermore, the results demonstrated a significant
increase in both TGF-β and TNF-α in cases and controls (P
= 0.0001), but there was no significant difference between
the two groups in terms of changes in TGF-β or TNF-α (P =
0.77, P = 0.73, respectively) (as shown in Figure 2).
The multivariate analysis did not reveal any impact
of age (P = 0.59) or sex (P = 0.57) on the change in the
cytokines. Meanwhile, there was no relationship between
the product age and cytokine status (P = 0.59, 0.73 for
TGF-β and TNF-α, respectively) (data not shown).
4. Discussion
Allogeneic blood transfusion is associated with
postoperative complications due to the effects, referred to
as TRIM. For the first time, the study by Opelz in the 1970s
revealed improved renal allograft survival in previously
transfused patients compared to nontransfused patients (9).

Table1. Inclusion and exclusion criteria.
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Inclusion criteria

Exclusion criteria

Age 40–60 years
Hemoglobin concentration > 100 g/L
Hematocrit > 30%
Weight > 60 kg

Active infection
Active inflammatory disease
Previous blood transfusion
Taking immunosuppressive drugs or on chronic anticoagulation
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Table 2. Laboratory parameters of peripheral blood.

Variables
Blood sugar (mg/dL)
Hb (g/dL)
Hct (%)

Analysis
n

Control

Case

35
35
35

101.71 ± 20.36
14.06 ± 1.49
42.65 ± 3.99

111.69 ± 34.90
12.81 ± 1.83
39.14 ± 6.36

Control: nontransfused patient group; Case: transfused patient group
Table 3. Serum levels of TGFβ and TNFα in the control group.
Analysis

Concentration of cytokines
TGF-β (pg/mL)
TNF-α (pg/mL)

n

1st

2nd

35
35

612.47 ± 162
90.14 ± 36

1373.54 ± 447
120.67 ± 46

1st analysis: before operation; 2nd analysis: after operation
Table 4. Serum levels of TGFβ and TNFα in the case group.

Concentration of cytokines
TGF-β (pg/mL)
TNF-α (pg/mL)

Analysis
n

1st

2nd

35
35

634.37 ± 120
77.66 ± 33

1415.39 ± 143.72
± 48

1st analysis: before operation; 2nd analysis: after operation

Some of the possible adverse clinical effects of TRIM
include increased risk of cancer recurrence, postoperative
infection, and short-term mortality. However, the clinical
signiﬁcance of TRIM remains controversial (10). The
precise mechanisms of TRIM are still not well understood
although presumed to be mediated by allogeneic
leukocytes and its products including the HLA peptides
and cytokines (11).
Allogeneic RBC transfusion can be associated with
the variations in cytokines. Dzik et al. presupposed that
blood transfusion can stimulate the synthesis of the
immunosuppressive cytokine TGF-β. Consequently
concentrations of TGF-β and TNF-α in peripheral blood
of orthopedic surgery patients after RBC transfusion were
analyzed (12).
Changes in Th1 to Th2 ratio and inclination to Th2, and
induction of tolerance are some debated issues in allogeneic
blood transfusion. Increases in IL-4 and IL10 and reductions
in IL-2, IL-12, and IFN-γ secretion have been observed in

posttransfusion experimental models in vitro. Changes
in cytokines are detectable 3 days after transfusion and
at least for 2 weeks (13,14). In addition to the mentioned
cytokines, secretion of TGF-β and prostaglandin E2 has
also been brought up after transfusion. Both of these factors
contribute to the inhibition of cell-mediated immunity
(CMI) and strong Th2 response to a specific antigen and
may lead to an increase in TGF-β and in turn nonspecific
attenuation of immune response (15).
Bleeding-related immunomodulation is mostly covered
by operation-related immunomodulation effects. A
significant increase in TGF-β in blood has been observed
in experimental models 24 h after bleeding. This is
accompanied by proliferative response to concanavalin A
and antigen presentation by spleen macrophages. Reduction
in spleen T cells proliferation occurs with an increase in IL-4
and IL-10. Administration of ibuprofen as an inhibitor of
cyclooxygenase pathway or anti-TGF-β antibodies impedes
the production of these two cytokines (16,17).
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Figure 1. Concentrations of TGF-β and TNF-α in the case and control groups.

Figure 2. Basal and postoperation concentrations of TGF-β and TNF-α in the case (blue) and control (green) groups.

Considering the fact that surgery as an invasive
and inflammatory process and blood transfusion as
an immunomodulatory factor may affect the profile of
cytokines, it is interesting to observe the quality of the
changes in TNF-α and TGF-β. Therefore, the serum levels
of TNF-α and TGF-β were analyzed in this study.
Previously Sablotski et al. performed a similar study
in cardiovascular operation patients. They assessed
plasma levels of IL-10 and TGF-β in 30 patients who
had experienced elective coronary artery bypass surgery
in order to determine levels of immunosuppressive
cytokine secretion during cardiopulmonary bypass (CPB).
The results suggested that plasma levels of IL-10 and
TGF-β significantly increase after CPB and reach their
maximum during skin closure. They also showed that IL10 and TGF-β levels are reduced 6 h after the operation.
Considering these findings, they stated that both cytokines
are major immunoregulatory factors and have negative
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effects on T cell-mediated immunologic response. The
significantly increased levels of IL-10 and TGF-β at the
end of CPB suggest that they may be important factors in
dysregulation of the immune system following CPB (18).
In the same study by Sitniakowsky et al., the effect
of red blood cell transfusion during cardiac surgery on
TGF-β and TNF-α gene expression was investigated. Their
results showed that these patients have increased gene
expression after surgery and blood transfusion (19).
Gulhan et al. determined the cytokine changes after
transfusion in patients with thalassemia major and
reported that TGF-β rates were decreased after blood
transfusion (20).
In Biedler et al.’s study, TNF-α and IL-10, which
were selected as prototypical proinflammatory and
antiinflammatory cytokines, respectively, were assessed.
They suggested that blood transfusion may in part
insert its immunosuppressive effects through induction
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of Th2-derived production of IL-10. Their investigation
demonstrated that leukocytes are not responsible per se, since
fresh allogeneic blood with normal numbers of leukocytes
had no significant effect on IL-10 or TNF-α secretion (21).
A similar study was conducted by Milasiene et al. on
colorectal cancer patients to determine the changes in TGF-β
and TNF-α levels after blood transfusion. The results showed
increases in these two cytokines (22).
Furthermore, the study by Miki et al. in the same patients
demonstrated that the plasma level of IL-6 is elevated in
transfused patients (23).
The design of the present study entails a few problems
that might limit the validity of our results. First, transfused

patients presented with lower preoperative hemoglobin and
hematocrit levels, as well as longer surgery duration. Second,
due to the high cost of ELISA kits, we limited our study to
only two cytokines.
Considering the results of previous reports, increased
levels of TNF-α and TGF-β are probably related to surgery
and packed cell transfusion, respectively. The data of our
study corroborate the findings of other investigators,
who showed that allogenic RBC transfusion might exert
immunomodulatory effects. Further studies using more
packed cell units or other blood products and assessment
of more cytokines are needed to have better understanding
about this issue.
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